Literature DB >> 20122345

Evaluation of bacterial biofilms in chronic rhinosinusitis.

Semih Oncel1, Ercan Pinar, Gamze Sener, Caglar Calli, Umit Karagoz.   

Abstract

OBJECTIVE: We investigated the presence of biofilms in patients with chronic rhinosinusitis.
DESIGN: Prospective study.
METHODS: Thirty patients with chronic rhinosinusitis scheduled for endoscopic sinus surgery were enrolled in this study. Nasal swab cultures were taken at the time of surgery. Samples were cultured using conventional methods for Haemophilus influenzae, Pseudomonas aeruginosa, Streptococcus pneumoniae, and Staphylococcus aureus. MAIN OUTCOME MEASURES: Culture-positive samples were evaluated for slime-forming ability. Qualitative detection of biofilm formation by all slime-producing strains was studied by culturing the strains on Congo red agar plates.
RESULTS: Twenty-three of 30 patients' samples were culture positive (76.6%). Thirteen S. aureus and 10 P. aeruginosa cultures were identified on 23 specimens. Bacterial biofilms were present on 15 of 23 (65.2%) culture-positive specimens. Nine of 13 (69.2%) S. aureus cultures and 6 of 10 (60%) P. aeruginosa cultures produced bacterial biofilms.
CONCLUSION: This conventional method is capable of demonstrating biofilm-forming ability in bacteria recovered from patients with chronic rhinosinusitis. The biofilm-forming ability was higher in S. aureus compared with P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122345

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


  10 in total

Review 1.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

Review 2.  Role of fungi in the pathophysiology of chronic rhinosinusitis: an update.

Authors:  Kathleen T Montone
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

Review 3.  The nasal and sinus microbiome in health and disease.

Authors:  Michael T Wilson; Daniel L Hamilos
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

4.  Prevention of Bacterial Biofilm Formation on Soft Contact Lenses Using Natural Compounds.

Authors:  Amira M El-Ganiny; Ghada H Shaker; Abeer A Aboelazm; Heba A El-Dash
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-04-18

5.  The Therapeutic Effect of 1,8-Cineol on Pathogenic Bacteria Species Present in Chronic Rhinosinusitis.

Authors:  Matthias Schürmann; Felix Oppel; Martin Gottschalk; Björn Büker; Christian Andreas Jantos; Cornelius Knabbe; Andreas Hütten; Barbara Kaltschmidt; Christian Kaltschmidt; Holger Sudhoff
Journal:  Front Microbiol       Date:  2019-10-22       Impact factor: 5.640

6.  Study of biofilm formation in bacterial isolates from contact lens wearers.

Authors:  L Raksha; Nagaraju Gangashettappa; G B Shantala; Bhavna R Nandan; Deepa Sinha
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

7.  The difference in pathogenic bacteria between chronic rhinosinusitis in patients with and without Sjogren's syndrome: a retrospective case-control study.

Authors:  Pei-Rung Yang; Wei-Tai Shih; Yao-Hsu Yang; Chia-Yen Liu; Ming-Shao Tsai; Yao-Te Tsai; Cheng-Ming Hsu; Ching-Yuan Wu; Pey-Jium Chang; Geng-He Chang
Journal:  BMC Infect Dis       Date:  2022-08-02       Impact factor: 3.667

Review 8.  Nontypeable Haemophilus influenzae biofilms: role in chronic airway infections.

Authors:  W Edward Swords
Journal:  Front Cell Infect Microbiol       Date:  2012-07-25       Impact factor: 5.293

9.  Efficacy of silk fibroin-nano silver against Staphylococcus aureus biofilms in a rabbit model of sinusitis.

Authors:  Minghui Jia; Zhongchun Chen; Yongwei Guo; Xin Chen; Xia Zhao
Journal:  Int J Nanomedicine       Date:  2017-04-10

Review 10.  Host-microbial interactions in patients with chronic rhinosinusitis.

Authors:  Daniel L Hamilos
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.